Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
Quest Diagnostics Inc DGX
News
-
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease
Q4HE Initiative Recognized for Efforts To Reduce Health Disparities
My Quest Story - Jessica Clow
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
My Quest Story - Pauline Chaves
She Is Not Skipping a Beat, and Patients Are Noticing
Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease
My Quest Story - Eddy Hurst
Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
Quest Colleague Is Exhibiting Care for Every Patient in Her Chair
Phlebotomist's Actions Keep One Patient Coming Back
My Quest Story - Allan Mendez
First PFAS "Forever Chemicals" Consumer-Initiated Blood Test With Physician Consult Launches on questhealth.com
On Rare Disease Day, Q4HE Collaboration Highlights Purpose in Action
Ten Years Running: FORTUNE Names Quest Diagnostics One of 2024 "World's Most Admired Companies"
Living Our Purpose - Ivelisse Lugo
Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference
Quest Diagnostics and Instacart Collaborate To Reduce Food Insecurity Across the United States With Integrated Patient Health Coaching and Nutritious Grocery Delivery
Quest Diagnostics and Instacart Collaborate to Reduce Food Insecurity Across the United States with Integrated Patient Health Coaching and Nutritious Grocery Delivery